Biglycan anticorps (C-Term)
-
- Antigène Voir toutes Biglycan (BGN) Anticorps
- Biglycan (BGN)
-
Épitope
- C-Term
-
Reactivité
- Humain, Souris
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Biglycan est non-conjugé
-
Application
- ELISA, Immunofluorescence (IF)
- Fonction
- Biglycan Preproprotein
- Séquence
- DRLAIQFGNY KK
- Réactivité croisée
- Chien, Humain, Souris, Rat
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Classe de qualité
- Verified
- Immunogène
- Peptide with sequence C-DRLAIQFGNYKK, from the C Terminus of the protein sequence according to NP_001702.1.
- Isotype
- IgG
- Top Product
- Discover our top product BGN Anticorps primaire
-
-
- Indications d'application
- Peptide ELISA: antibody detection limit dilution 1:2000.
- Commentaires
-
Immunofluorescence: Expression of the protein seen in the Golgi of NIH3T3 and HepG2 cells. Recommended concentration: 10μg/ml.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Minimize freezing and thawing.
- Stock
- -20 °C
- Stockage commentaire
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
Arguments for an increasing differentiation towards fibrocartilaginous components in midportion Achilles tendinopathy." dans: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, Vol. 21, Issue 6, pp. 1459-67, (2013) (PubMed).
: "
-
Arguments for an increasing differentiation towards fibrocartilaginous components in midportion Achilles tendinopathy." dans: Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, Vol. 21, Issue 6, pp. 1459-67, (2013) (PubMed).
-
- Antigène
- Biglycan (BGN)
- Autre désignation
- BGN (BGN Produits)
- Synonymes
- anticorps DSPG1, anticorps PG-S1, anticorps PGI, anticorps SLRR1A, anticorps BG, anticorps BSPG1, anticorps bgn, anticorps zgc:91989, anticorps dspg1, anticorps pg-s1, anticorps slrr1a, anticorps xbgn, anticorps BGN, anticorps zgc:77123, anticorps DKFZp468I2427, anticorps biglycan, anticorps biglycan L homeolog, anticorps biglycan a, anticorps biglycan S homeolog, anticorps biglycan b, anticorps BGN, anticorps Bgn, anticorps bgn.L, anticorps bgna, anticorps bgn.S, anticorps bgn, anticorps bgnb
- Sujet
- Biglycan Preproprotein, biglycan, BGN, DSPG1, PG-S1, PGI, SLRR1A , bone/cartilage proteoglycan-I, dermatan sulphate proteoglycan I, small leucine-rich protein 1A
- ID gène
- 633, 12111, 25181
- NCBI Accession
- NP_001702
- Pathways
- Glycosaminoglycan Metabolic Process
-